To determine the impact of apoC-III lowering on early stages of atherogenesis, we assessed atherosclerosis development after 8 weeks of ASO treatment by analyzing the aortic root and via en face analysis of the aorta. This evidence concerns the gene APOC3 and atherosclerosis.